Press coverage of Leaps and portfolio companies
02-13-2024
Sudo Biosciences Announces Second Close of Upsized Series B Financing Bringing Total Raised in Round to $147M
Read01-06-2024
Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals
Read11-09-2023
Bayer and Recursion focus research collaboration on Oncology
Read10-05-2023
65LAB Launches in Partnership with Evotec SE and Backed by Leading Global Investors to Advance Drug Discovery and New Company Creation in Singapore
Read08-29-2023
Gene Editing: Pairwise and Bayer start new five-year multi-million Dollar collaboration to further advance short-stature corn
Read05-16-2023
Boundless Bio Announces $100 Million Series C Financing co-led by Leaps by Bayer and RA Capital Management to Advance First ecDNA-Directed Therapies for Patients with Oncogene Amplified Cancer
Read05-10-2023
ChrysaLabs Secures CA $15 Million ($11 Million) Series A Funding to Increase Instant Access to Reliable and Low-Cost Soil Insights, Including Carbon Verification
Read02-27-2023
What can bats, naked mole rats and Jaws tell us about human biology? Paratus is on a $100M mission to find out
Read01-19-2023
Bayer launches new collaboration with Oerth Bio to further advance innovations in crop protection
Read01-10-2023
NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs
Read01-09-2023
AskBio Announces Strategic Collaboration with ReCode Therapeutics to Explore Single Vector Gene Editing Platform
Read11-03-2022
Leaps by Bayer leads investment round in AgTech pioneer NuCicer to bring unique and cost-effective plant-protein ingredients to market by 2023
Read09-14-2022
Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering
Read08-01-2022
Bayer expands existing investment to acquire majority share in sustainable lower carbon oilseed producer CoverCress Inc.
Read06-29-2022
ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M
Read03-22-2022
Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations
Read03-15-2022
Woebot Health Secures $9.5 Million Investment From Leaps by Bayer
Read02-10-2022
Indapta Therapeutics Names Mark W. Frohlich, M.D., Chief Executive Officer and Raises Over $50 Million in Series A Financing and Commitments to Advance Development of G-NK Cell Therapy to Treat Multiple Types of Cancer
Read01-31-2022
Gandeeva Raises $40M in Series A Funding to Develop Novel Therapies Based on Precision Imaging of Protein-Drug Interactions
Read01-25-2022
Leaps by Bayer leads $80M Series A Financing for Cellino Biotech to Autonomize Stem Cell Therapy Manufacturing
Read12-09-2021
Bloom Science Raises USD $12 Million in Series A Financing
Read11-21-2021
Immunitas Therapeutics Launches with $39 Million to Advance Lead Programs to Human Efficacy Studies Based on a Unique Immunology-Focused Drug Development Platform
Read11-16-2021
Deka Biosciences Raises USD 20 Million in Series A Financing
Read11-03-2021
GRO Biosciences Announces $25M Series A Financing Led by Leaps by Bayer and Redmile Group
Read10-26-2021
Mozart Therapeutics Launches with $55 Million Series A Financing to Develop Disease Modifying Therapeutics for Autoimmune and Inflammatory Diseases
Read09-21-2021
EarthOptics Raises $10.3 million in Series A Funding, Led by Leaps by Bayer, to Accelerate Carbon Mapping
Read08-01-2021
Leaps by Bayer Leads USD 45 Million Financing in Sound Agriculture to Accelerate Sustainability Solutions for Food and Agriculture
Read06-09-2021
Kojin Therapeutics Launches with $60 Million Series A to Develop New Category of Drugs Based on Cell State Biology
Read05-27-2021
Leaps by Bayer leads USD 90 Million Series B financing in digital health company Ada Health
Read04-22-2021
Edifice, a Healthcare Disruptor spun out of Stanford, Raises $12 Million to Reinvent Immune Health, Improve Healthspan, and Change Course of Aging
Read04-06-2021
Guardian Agriculture Launches With $10.5 Million Financing to Modernize Crop Protection With eVTOL-Powered Precision
Read03-23-2021
Amfora Raises $6 Million with Investment from Leaps by Bayer and Spruce Capital Partners
Read01-27-2021
Ukko secures USD 40 million in Series B funding led by Leaps by Bayer to overcome food allergies and sensitivities
Read01-06-2021
Leaps by Bayer leads Series B financing in Senti Bio to develop next-generation cell and gene therapies using advanced gene circuit technology platform
Read12-02-2020
Bayer backs drone spraying platform Rantizo in $7.5m Series A round
Read11-12-2020
Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund
Read10-15-2020
Leaps by Bayer leads USD 17 million Series B financing in biotech company Azitra
Read09-09-2020
Bayer collaborates with Recursion to strengthen efforts in digital drug discovery and advance new therapies for fibrotic diseases.
Read
Our return
to humanity
The Leaps team brings together a diverse group of individuals with expertise in biotech, healthcare, agriculture, investment, and communication.